New ways to treat severe dengue
Part of Infections clinical trials.
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed dengue infection (tested positive with a blood test)
- You have fever plus at least two of: muscle aches, joint pain, nausea or vomiting, rash, or low white blood cell count
- You may be eligible if your dengue is mild, moderate (with warning signs), or severe
- Children and adults may be included (age not specified in the criteria provided)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.
This trial studies whether dexamethasone (a steroid medicine) can help people with dengue infection who have warning signs and are still in the fever stage. It may help reduce complications like breathing problems, severe bleeding, or organ stress, but it is only for a specific window and situation.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.
This study tests a controlled dengue infection in volunteers who already have immunity to some dengue types. It aims to see how safe it is and how the immune system responds, which could help develop better vaccines.
Hear when a new Severe Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.